IRCT20200525047562N1招募中3 期
Immediate uses of convalescent covid-19 plasma in the treatment of new infected patients at the first day of hospitalization in a clinical trail
High Educational and Research Institute of Transfusion Medicine0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Symptomatic COVID-19 patients who are hospitalized and have Score>4 in terms of WHO Progression Scale.
- •The least reasons of hospitalization are dyspnea and/or SPO2<93% or RR>30
- •The intervention should be performed within the first 24 hours of hospitalization.
排除标准
- •COVID-19 patients having Score<4 in terms of WHO Progression Scale.
- •More than 24 hours passed from hospitalization.
研究者
相似试验
招募中
不适用
se of Convalescent Plasma in the treatment of COVID-19IRCT20200414047072N1Hilton Pharma Pvt. Ltd.357
招募中
2 期
Efficacy of convalescent plasma transfusion of COVID-19 survivors on the treatment of respiratory failure of these patientsIRCT20200406046968N2Tabriz University of Medical Sciences30
尚未招募
不适用
Vaccine Plasma for the Treatment of COVID-19 InfectioCOVID-19SARS-CoV-2C01.748.214RBR-2ggx7smMinistério da Ciência, Tecnologia e Inovações
进行中（未招募）
不适用
"NORPLASMA" Covid-19 Convalescent Plasma Treatment Monitoring StudyCOVIDNCT04463823Oslo University Hospital500
进行中（未招募）
2 期
sing blood plasma to develop passive immunity to coronavirus in EcuadorISRCTN85216856niversidad Tecnológica Equinoccial200